Andrew Sklawer

Insider Reports History

Entity
Individual
Location
5777 Central Avenue, Suite 102, Boulder, CO
Signature
/s/ Christine G. Long, Attorney-in-Fact for Andrew Sklawer (power of attorney previously filed)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Sklawer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fresh Tracks Therapeutics, Inc. President and CEO Common Stock 39.3K $38.9K $0.99 Oct 2, 2023 Direct
Fresh Tracks Therapeutics, Inc. President and CEO Restricted Stock Units 0 $0.91 Oct 2, 2023 Direct

Insider Reports Filed by Andrew Sklawer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FRTX Fresh Tracks Therapeutics, Inc. Oct 2, 2023 3 -$20.4K 4 Oct 4, 2023 President and CEO
FRTX Fresh Tracks Therapeutics, Inc. Jan 24, 2023 1 $0 4 Jan 26, 2023 President
FRTX Brickell Biotech, Inc. May 5, 2022 1 $0 4 May 9, 2022 COO and Secretary
FRTX Brickell Biotech, Inc. Jun 14, 2021 1 $0 4 Jun 14, 2021 COO and Secretary
FRTX Brickell Biotech, Inc. May 17, 2021 1 $12.3K 4 May 19, 2021 COO and Secretary